GBLI Global Indemnity Group, LLC

NYSE gbli.com


$ 29.25 $ 0.06 (0.21 %)    

Monday, 03-Nov-2025 14:31:59 EST
QQQ $ 631.76 $ -3.46 (-0.54 %)
DIA $ 473.80 $ -2.31 (-0.49 %)
SPY $ 683.24 $ -2.40 (-0.35 %)
TLT $ 89.61 $ -0.04 (-0.04 %)
GLD $ 368.21 $ -0.59 (-0.16 %)
$ 29.2499
$ 29.19
$ 28.93 x 15
$ 29.86 x 100
$ 29.10 - $ 29.50
$ 26.34 - $ 35.83
2,009
na
435.06M
$ 0.17
$ 15.84
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-31-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-11-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-15-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-10-2022 03-31-2022 10-Q
16 03-16-2022 12-31-2021 10-K
17 11-09-2021 09-30-2021 10-Q
18 08-06-2021 06-30-2021 10-Q
19 05-10-2021 03-31-2021 10-Q
20 03-12-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 08-10-2020 06-30-2020 10-Q
23 05-08-2020 03-31-2020 10-Q
24 03-06-2020 12-31-2019 10-K
25 11-08-2019 09-30-2019 10-Q
26 08-09-2019 06-30-2019 10-Q
27 05-10-2019 03-31-2019 10-Q
28 03-14-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-09-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-09-2017 06-30-2017 10-Q
35 05-10-2017 03-31-2017 10-Q
36 03-10-2017 12-31-2016 10-K
37 11-04-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-14-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 global-indemnity-to-transfer-listing-of-class-a-common-shares-from-nyse-to-nasdaq-effective-november-3

Global Indemnity Group, LLC (NYSE:GBLI) ("Global Indemnity" or the "Company") today announced that it will tran...

 global-indemnity-subsidiary-pau-acquires-sayata-to-accelerate-agency-services-and-digital-insurance-distribution-terms-not-disclosed

Global Indemnity Group, LLC (NYSE:GBLI) ("GBLI"), announced today that its subsidiary Penn-America Underwriters, LLC (&...

 global-indemnity-group-q2-adj-eps-071-misses-077-estimate-sales-110520m-miss-120291m-estimate

Global Indemnity Group (NYSE:GBLI) reported quarterly earnings of $0.71 per share which missed the analyst consensus estimate o...

 global-indemnity-group-q1-adj-eps-030-misses-023-estimate-sales-10865m-miss-11300m-estimate

Global Indemnity Group (NYSE:GBLI) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate o...

 global-indemnity-group-q4-adj-eps--065-misses-077-estimate-sales-10845m-miss-11400m-estimate

Global Indemnity Group (NYSE:GBLI) reported quarterly earnings of $0.65 per share which missed the analyst consensus estimate o...

 global-indemnity-group-q3-2024-adj-eps-095-beats-057-estimate-sales-111761m-miss-123000m-estimate

Global Indemnity Group (NYSE:GBLI) reported quarterly earnings of $0.95 per share which beat the analyst consensus estimate of ...

 global-indemnity-group-q2-2024-adj-eps-072-beats-052-estimate-sales-108687m-miss-114000m-estimate

Global Indemnity Group (NYSE:GBLI) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of ...

 global-indemnity-group-q1-2024-adj-eps-077-beats-060-estimate-sales-112291m-down-from-150914m-yoy

Global Indemnity Group (NYSE:GBLI) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of ...

 earnings-scheduled-for-march-13-2024

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

 global-indemnity-group-llc-announces-increase-in-quarterly-dividend-from-025-to-035-per-share

Global Indemnity Group, LLC (NYSE:GBLI) ("GBLI") announced today that its Board of Directors approved a dividend rate o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION